Literature DB >> 402383

Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.

T Sato, Y Suzuki, T Taketani, K Ishiguro, H Nakajima.   

Abstract

Nine patients with athyrotic or ectopic cretinism ages 6 mo.-17 yrs-were studied to examine the relation between age and the quantities of oral L-thyroxine (T4) adequate to restore TSH hypersecretion to normal levels by feedback control. All but one patient had very low levels of endogenous T4 (below 1.0 mug/100 ml) before treatment. However, based on clinical signs and serum T4-1 values, all were judged to be euthyroid or sub-clinically hyperthyroid by L-T4 replacement during the observation period. L-T4 dosage was increased or decreased by 25 or 50 mug/day at 2-12 mo. intervals, and the TSH response to exogenous thyrotropin-releasing hormone (TRH) was tested sequentially at each dose of L-T4 until a normal or slightly suppressed TSH response was obtained The L-T4 dosage which was associated with normal TSH responsiveness to TRH (the adequate L-T4 dose) was high in infancy (10 mug/kg/day), decreasing with age to a level of 3-4 mug/kg/day in pubertal children (correlation coefficient r=-0.820, P less than 0.01). The adequate L-T4 dose observed between 4 and 12 yrs of age was lower than the usually recommended dose (4-6 vs. 7-8 mug/kg/day). On these L-T4 doses, serum T4I concentrations were significantly higher in patients under 5 yrs of age than in older patients (8.3+/-1.5 vs. 6.5+/-0.7 mug/100 ml, P less than 0.02). Serum triiodothyronine (T3) values were also elevated in young children, decreasing with age to the normal range. TSH responses to TRH were completely suppressed at the serum T4-I levels of 9 mug/100 ml and T3 of 250 ng/100 ml or less in 7 patients over 4 yrs of age, but not in 2 younger patients. Although the number of patients examined was limited, these results suggest that the pituitary threshold for feedback regulation of TSH secretion by T4 decreases with age in children with cretinism and the usually recommended replacement doses of L-T4 between 4 and 12 yrs of age are probably overestimated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402383     DOI: 10.1210/jcem-44-3-553

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Reappraisal of thyroxine treatment in primary hypothyroidism.

Authors:  S Hodges; B P O'Malley; B N Northover; K L Woods; P G Swift
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Monitoring TSH concentrations during treatment for congenital hypothyroidism.

Authors:  D B Grant
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 3.  Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate.

Authors:  E Roti
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

4.  Screening for congenital hypothyroidism: the first decade.

Authors:  N D Barnes
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

5.  Partial end organ resistance to thyroid hormone in congenital hypothyroidism.

Authors:  J M Connell; E H McLaren
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

6.  Prognostic factors in the intellectual development at 7 years of age in children with congenital hypothyroidism.

Authors:  M Salerno; S Di Maio; R Militerni; A Argenziano; G Valerio; A Tenore
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

7.  Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.

Authors:  L Chiovato; L Giusti; M Tonacchera; M Ciampi; C Mammoli; F Lippi; P Lapi; S Bargagna; P Dini; G Ferretti
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

8.  Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine.

Authors:  D B Grant; P W Fuggle; I Smith
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

9.  Management of patients with congenital hypothyroidism.

Authors:  G J Frost; J M Parkin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

10.  Soy formula complicates management of congenital hypothyroidism.

Authors:  S C Conrad; H Chiu; B L Silverman
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.